[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ginkgo Bioworks Hldgs Inc (DNA)

Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 552,981
  • Shares Outstanding, K 61,924
  • Annual Sales, $ 170,160 K
  • Annual Income, $ -312,760 K
  • EBIT $ -315 M
  • EBITDA $ -260 M
  • 60-Month Beta 1.77
  • Price/Sales 3.76
  • Price/Cash Flow N/A
  • Price/Book 1.18

Options Overview Details

View History
  • Implied Volatility 102.05% (-24.52%)
  • Historical Volatility 104.00%
  • IV Percentile 57%
  • IV Rank 47.81%
  • IV High 133.13% on 10/22/25
  • IV Low 73.59% on 06/20/25
  • Expected Move (DTE 5) 0.94 (10.47%)
  • Put/Call Vol Ratio 0.14
  • Today's Volume 1,158
  • Volume Avg (30-Day) 849
  • Put/Call OI Ratio 0.46
  • Today's Open Interest 17,114
  • Open Int (30-Day) 13,528
  • Expected Range 8.00 to 9.87

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Sell
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $-1.10
  • Growth Rate Est. (year over year) +90,918.18%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.16 +44.85%
on 04/13/26
10.64 -16.07%
on 05/07/26
+2.05 (+29.80%)
since 04/08/26
3-Month
5.37 +66.29%
on 03/30/26
10.64 -16.07%
on 05/07/26
-1.17 (-11.58%)
since 02/06/26
52-Week
5.37 +66.29%
on 03/30/26
17.58 -49.20%
on 10/08/25
+1.06 (+13.47%)
since 05/08/25

Most Recent Stories

More News
Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab

Ginkgo provides an update on its first quarter financial results following the divestiture of its Biosecurity business

DNA : 8.93 (-13.47%)
Ginkgo Bioworks Reports Earnings Tomorrow, But the Autonomy Pivot Remains Unproven

Barchart Research What to Expect from DNA Earnings DNA Generated May 6, 2026 Current Price $10.08 Consensus Rating Moderate Sell Average Move 13.93% Ginkgo Bioworks Reports Earnings Tomorrow, But the Autonomy...

DNA : 8.93 (-13.47%)
Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation

Presentation and Q&A session scheduled for post-market on Thursday, May 7, 2026

DNA : 8.93 (-13.47%)
Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure

BOSTON , March 2, 2026 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced the official launch of Ginkgo Cloud Lab. This new interface allows researchers to transition their benchwork to...

DNA : 8.93 (-13.47%)
Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business

Ginkgo provides an update on its fourth quarter financial results

DNA : 8.93 (-13.47%)
Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results Presentation

Presentation and Q&A session scheduled for post-market on Thursday, February 26, 2026

DNA : 8.93 (-13.47%)
Ginkgo Bioworks and Invaio Sciences Enter Collaboration to Develop Manufacturing Technology for Peptide-based Agricultural Products

BOSTON , Feb. 18, 2026 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA, "Ginkgo") and Invaio Sciences, an agricultural biotechnology company leading in nature-positive crop protection solutions, today...

DNA : 8.93 (-13.47%)
Ginkgo Bioworks' Autonomous Laboratory Driven by OpenAI's GPT-5 Achieves 40% Improvement Over State-of-the-Art Scientific Benchmark

BOSTON , Feb. 5, 2026 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced it has demonstrated, in collaboration with OpenAI, an AI system that autonomously designed, executed, and learned...

DNA : 8.93 (-13.47%)
Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference

BOSTON , Jan. 13, 2026 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) announced today that Co-Founder and CEO Jason Kelly is scheduled to present at the 44th Annual J.P. Morgan Healthcare Conference...

DNA : 8.93 (-13.47%)
Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach

BOSTON , Dec. 22, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced its partnership with Carnegie-Mellon University (CMU) for an award by the Advanced Research Projects Agency for...

DNA : 8.93 (-13.47%)

Business Summary

Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is based in NEW YORK.

See More

Key Turning Points

3rd Resistance Point 10.73
2nd Resistance Point 10.13
1st Resistance Point 9.53
Last Price 8.93
1st Support Level 8.34
2nd Support Level 7.75
3rd Support Level 7.15

See More

52-Week High 17.58
Fibonacci 61.8% 12.92
Fibonacci 50% 11.48
Fibonacci 38.2% 10.03
Last Price 8.93
52-Week Low 5.37

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.